PMRG Elects M3 Global Research President to the 2017 Board of Directors

December 7, 2016

FORT WASHINGTON, PA (December 7, 2016) — Pharmaceutical Market Research Group (PMRG), elected Roni DasGupta, President of M3 Market Research, to the 2017 Board of Directors. The Board of PMRG is comprised of the President, Vice President, Chairman and Directors-at-Large. Ms. DasGupta previously held the Secretary position under the 2016 Executive Committee.

“We are very proud to have this important representation at PMRG.” Said Craig Overpeck, Chief Technology Officer of M3 USA. “Roni and M3 can contribute significantly to the Pharmaceutical Market Research industry, with years of experience in healthcare market research, and a commitment to empowering members and future generations with knowledge.”

President of Market Research, Americas, at M3 Global Research, DasGupta has over 18 years of experience in the market research industry, and has enjoyed significant success since early in her career. She is also the founder of PMRG Charities, serves as PMRG Secretary, and is on the EphMRA board of ethics.

PMRG is an independent, non-profit trade association which stimulates the advancement of marketing research in the healthcare industry. PMRG serves U.S. and global end-client researchers and service providers representing pharmaceuticals, biologics, medical/surgical devices and diagnostics. Founded in 1961, PMRG is one of the oldest associations of its kind, and has stood the test of time, evolving from a small association to a thriving national organization infused with numerous volunteers, educational events, conferences and networking opportunities.

About M3 Inc.

M3 Inc. operates in the US, Asia, and Europe with over 3.5 million physician members globally via its physician portals including,,,,, M3 Medical and M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (TYO:2413) with subsidiaries in major markets including USA, UK, Japan, S. Korea, and China. M3 Inc. provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, Beijing, and Seoul.